892568-95-5 Usage
Description
Cyclopropyl-(2,4-dichloro-benzyl)-amine is a chemical compound that features a cyclopropyl group connected to a 2,4-dichloro-benzylamine moiety. Known for its structural stability due to the cyclopropyl group, this compound is a valuable intermediate in the synthesis of a variety of organic compounds and pharmaceuticals. Its potent biological activities and potential for disease treatment make it a versatile and promising candidate in the fields of chemistry and medicine.
Uses
Used in Pharmaceutical Synthesis:
Cyclopropyl-(2,4-dichloro-benzyl)-amine is utilized as a key intermediate in the development of new pharmaceuticals, contributing to the creation of innovative drugs for various medical conditions.
Used in Organic Compound Synthesis:
Cyclopropyl-(2,4-dichloro-benzyl)-aMine serves as an essential building block in the synthesis of a range of organic compounds, facilitating the advancement of chemical research and product development.
Used in Drug Development:
Due to its potent biological activities, Cyclopropyl-(2,4-dichloro-benzyl)-amine is being explored for its potential role in treating various diseases, making it a significant component in the field of medicinal chemistry.
Used in Material Science:
The structural stability of Cyclopropyl-(2,4-dichloro-benzyl)-amine also makes it a valuable component in the development of new materials with specific properties for use in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 892568-95-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,2,5,6 and 8 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 892568-95:
(8*8)+(7*9)+(6*2)+(5*5)+(4*6)+(3*8)+(2*9)+(1*5)=235
235 % 10 = 5
So 892568-95-5 is a valid CAS Registry Number.
892568-95-5Relevant articles and documents
NOVEL COMPOUNDS AS INHIBITORS OF RENIN
-
Page/Page column 9, (2012/05/20)
The present invention relates to novel renin inhibitors of general formula (1), novel intermediates involved in their synthesis, their pharmaceutically acceptable salts and pharmaceutical compositions containing them. The present invention also relates to
